|
|
|
|
| Prevention & treatment of DVT and PE |
Explains the treatments that your doctor may prescribe when you have a diagnosed blood clot. |
|
| Other articles on thrombosis: |
|
Treatment of thrombosis occurs when you have a diagnosed deep-vein thrombosis (DVT) or pulmonary embolism (PE) that needs to be treated. One of the most important aims of treatment is to prevent the blood clot from breaking into smaller pieces called emboli and travelling to other parts of the body (such as the lungs).
If you are at high risk of thrombosis (e.g. you need to undergo orthopedic surgery), you will be given medication in order to prevent the development of thrombosis.
There are a variety of options, in terms of medications and devices, available to prevent or treat thrombosis. The therapies used to prevent thrombosis may differ (e.g. in dose) from the therapies used to treat thrombosis.
The risks associated with a particular treatment option, the most common of which is bleeding, will depend on the type, dose and regimen (schedule) of the therapy. Your physician will only recommend those treatment options that he/she believes are appropriate for you and will provide you with most benefit while keeping your risk of deep-vein thrombosis (DVT) or pulmonary embolism (PE) as low as possible.
If you have any concerns about the treatment that you have been prescribed, or the effects it has, you must consult your physician.
Mechanical devices
| Mechanical devices that have been shown to be effective in the prevention of deep-vein thrombosis (DVT) in patients at risk of DVT include elastic graduated compression stockings and intermittent pneumatic compression. They are most often used after a surgical operation. Elastic graduated compression stockings increase the rate of blood flow through the veins in your legs. Pneumatic compression is achieved by wearing a plastic stocking that intermittently fills with air and squeezes your leg. This compression enhances blood flow in the deep veins and stimulates your body to produce factors that help to dissolve small blood clots. These methods are particularly useful in patients with a high risk of serious bleeding. |
 |
Side effects no significant side effects. Potential drug interactions not applicable. Monitoring of therapy your physician will ensure that you know how to apply these mechanical devices correctly, and that you are aware of when and for how long you should wear them.
|
Top Unfractionated heparin
| Unfractionated heparin (UFH) has been used for over 50 years in the prevention and treatment of thrombosis. For the treatment of deep-vein thrombosis (DVT) and pulmonary embolism (PE), it is administered by intravenous infusion (i.e. it is infused over a period of time into your vein) and has a rapid anticoagulant (anticlotting) effect. You have to be in hospital to receive this treatment. Low-dose UFH is commonly used for prevention of thrombosis (thromboprophylaxis) in patients who are undergoing general surgery, but it is less effective than other forms of prevention in high-risk patients who are undergoing major orthopedic surgery (e.g. hip or knee replacement surgery). |
 |
Side effects UFH is associated with a risk of bleeding, heparin-induced thrombocytopenia (low platelet count in the blood) and local reactions in the skin around the site of infusion. Long-term use of UFH may also be associated with an increased risk of osteoporosis (loss of bone tissue leading to brittle bones). If you experience any side effects, you must consult your physician. Potential drug interactions before you start taking UFH, you may be asked to stop taking any other treatments that may increase your risk of bleeding (e.g. other anticoagulants and platelet inhibitors, such as aspirin or nonsteroidal anti-inflammatory drugs). If your physician considers it is necessary for you to continue taking these treatments while you are taking UFH, he/she is likely to ensure that you are monitored very carefully. Monitoring of therapy if you are receiving treatment with UFH, the dose you receive has to be regularly monitored and adjusted to ensure that you are sufficiently protected from thromboses forming in your veins. Your physician will conduct a blood test (the activated partial thromboplastin time, or aPTT, test) 6 hours after the first dose and at least once a day thereafter to ensure that you are receiving the correct dose of UFH. |
Top Low-molecular-weight heparin
Low-molecular-weight heparin (LMWH) is derived from unfractionated heparin (UFH). It is injected under the skin (i.e. subcutaneous injection) and has a rapid anticoagulant (anticlotting) effect. LMWH has several advantages over UFH, including a predictable response to the dose of drug and a longer-lasting effect. This means that it can be administered only once or twice a day. It is also more convenient to inject under the skin than into a vein, which means that you may be able to inject yourself at home rather than having to go to hospital. LMWH is a highly effective and generally safe form of prevention (thromboprophylaxis) and treatment.
|
|

|
Side effects LMWH is associated with a small risk of bleeding (most commonly minor bleeding), thrombocytopenia (a low platelet count in the blood) and osteoporosis (loss of bone tissue leading to brittle bones). These side effects with LMWH are rare, with bleeding being the most common, but if you experience any side effects, you must consult your physician. Potential drug interactions Before you start taking LMWH, you may be asked to stop taking any other treatments that could increase your risk of bleeding (e.g. other anticoagulants and platelet inhibitors). If your physician considers it is necessary for you to continue undergoing these treatments while you are taking LMWH, he/she is likely to ensure that you are monitored very carefully. Monitoring of therapy LMWH is injected at a fixed dose decided in accordance with your weight. There is no need for your physician to monitor or adjust the amount of drug injected once the correct dose has been found (using a blood-clotting test), unless you are pregnant, have kidney failure, weigh more than 100 kg, or are a child.
|
Top
Low-dose aspirin
| Aspirin (acetylsalicylic acid) can prevent blood clots forming in the arteries and is therefore used in preventing problems such as heart attack and stroke. However, the usefulness of aspirin in the prevention of deep-vein thrombosis (DVT) or pulmonary embolism (PE) is not clear. Aspirin is inexpensive, easy to use and is effective very soon after it is administered. Aspirin is not used for the treatment of DVT or PE. |
Side effects Aspirin may irritate the lining of your stomach, which can occasionally lead to nausea, vomiting, pain and bleeding in the gut. It may also cause an allergic or asthmatic reaction. If you experience any side effects, you should consult your physician. Potential drug interactions Before you start taking aspirin, you may be asked to stop taking other treatments that could increase your risk of bleeding (e.g. other anticoagulants). Some of the medications that aspirin interacts with include the following: coumarin anticoagulants, hypoglycemic agents (diabetes drugs, particularly sulfonylureas), certain anti-inflammatory agents, corticosteroids and certain antacids. You should inform your physician if you are aware that you are taking any of these drugs and you are prescribed aspirin. Monitoring of therapy Aspirin therapy is not usually monitored with any tests. |
 |
Top
Oral anticoagulants
The oral anticoagulant warfarin has been used successfully for over 50 years in the prevention of thrombosis.
Warfarin is not recommended for the prevention of thrombosis in patients who are undergoing general surgery. Warfarin, dose-adjusted according to the results of a blood clotting test, is generally safe and effective in the prevention of thrombosis in patients who are undergoing major orthopedic operations (e.g. hip or knee replacement surgery).
Treatment of thrombosis using warfarin is usually started while you are in hospital and can be continued after you are discharged. Warfarin is generally safe; however, it is not effective until at least 3 days after you have taken it and it is only effective within a narrow range of doses (called a therapeutic window). For this reason, when you are first diagnosed with a deep-vein thrombosis (DVT) or pulmonary embolism (PE), you will be given either unfractionated heparin or low-molecular-weight heparin together with warfarin for the first few days (up to 1 week) until your blood test shows that the warfarin dosage is effective. |
 |
Side effects Warfarin is associated with a risk of bleeding complications. It may also cause rash, nausea and diarrhea. If you experience any side effects, you must consult your physician. Warfarin should be avoided during pregnancy. Potential drug interactions Drug interactions with warfarin can increase the anticogaulant effect which can result in bleeding, or decrease the anticoagulant effect which can lead to an increased risk of DVT. The following are some of the most important drugs with which warfarin interacts: |
- nonsteroidal anti-inflammatory drugs
- oral hypoglycemics (diabetes drugs)
- sulfonamides
- antibiotics
- drugs affecting liver enzymes (e.g. some cholesterol-lowering drugs, such as carbamazepine)
- corticosteroids
- imidazole antifungals (e.g. Amfotericin B, Fluconazole)
- vitamin K in food (foods that contain high levels of vitamin K include spinach, avocado and cabbage), and dietary supplements (vitamin K helps produce some important blood-clotting factors and decreases the effects of warfarin).
- Hormonal contraceptives in general
You should inform your physician if you are taking any of these drugs or dietary supplements and you are prescribed warfarin. You should also consult your physician for more complete advice on the drugs likely to interact with warfarin, and whether it is necessary to adjust your diet in order to avoid foods high in vitamin K. Monitoring of therapy if you are prescribed warfarin, you will usually be monitored frequently and closely to minimize the risk of serious bleeding complications. Your physician may also periodically conduct a blood test (the PT test) to ensure that you are receiving the correct dose of warfarin. The standardized method for reporting the results of this test is called the international normalized ratio (INR). The aim of your treatment will be to keep your INR within a certain range.
Top Other treatment options Other treatment options for deep-vein thrombosis or pulmonary embolism (PE) include thrombolytic therapy, thrombectomy and inferior vena cava interruption.
Thrombolytic medications Thrombolytic medications break down the blood clot, i.e. they cause the clot to disintegrate. They are usually used in combination with anticoagulants . These agents are very expensive and are associated with a high incidence of bleeding. They are not necessary for most patients with pulmonary embolism, but can be life-saving in patients with a very large pulmonary embolism that obstructs the flow of blood to the lungs.
Thrombectomy Thrombectomy is the surgical removal of a thrombosis. This technique is of limited use for blood clots in veins and is 50% successful in preventing a further thrombosis.
Inferior vena cava interruption Partial interruption of the inferior vena cava (the vein that carries blood from the lower body to the right side of the heart) using clips, sutures (stitches) or filters prevents the blood clot from reaching the lung. This technique is usually considered in situations where anticoagulant medication cannot be used because of bleeding, or in situations of repeated thrombosis despite the use of antithrombotic medication.
New medications The aim of development of a new medication is to provide a treatment that is at least as effective and safe as currently marketed products. Specifically, the goal in the development of new anticoagulant therapies is to provide a treatment that acts rapidly and effectively, has a low risk of bleeding, causes minimal side effects, is easy to use and has minimal interactions with other medications. Ideally, new medications should provide improved therapy for patients in comparison with existing ones.
Top Bleeding Although side effects are not common, the side effect that you may be most likely to experience while taking anticoagulant agents is bleeding. All anticoagulants are associated with an increased risk of bleeding. Your physician will decide if the benefits you will receive from anticoagulant therapy outweigh this risk.
Monitoring your bleeding Unusual bleeding may mean that your body is getting more anticoagulant medication than it needs. It is important that any unusual bleeding is monitored. You should make a note of when you bleed, how much blood you lose (a rough estimate is sufficient) and through which route the bleeding occurred (i.e. through your nose, in your bowel movements, urine, etc.). It is a good idea to make a record of any bleeding that you experience in a notebook or diary; you can then use this to describe any bleeding events to your physician.
If you experience any major bleeding, it is very important that you seek professional medical advice immediately.
If you are prescribed anticoagulant medication, you should pay particular attention to (and record) the following:
- bleeding in your eye
- more bleeding than normal from your gums when brushing your teeth
- blood in your bowel movements (or stools; be aware of your stools becoming black and tarry or pitchy)
- blood in your urine
- blood in your vomit
- coughing up of blood
- nosebleeds
- pinpoint red spots on your skin
- unusual bleeding or bruising
- unusually heavy bleeding or oozing from cuts or wounds
- unusually heavy or unexpected menstrual bleeding
In addition, you must monitor the following signs and symptoms of internal bleeding
- abdominal or stomach pain or swelling
- back pain or backaches
- blurred vision
- chest pain
- confusion
- diarrhea (sudden and severe)
- dizziness or fainting
- headache (continuing or severe)
- joint pain, stiffness or swelling
- loss of appetite
- nausea and vomiting (severe)
- nervousness
- numbness or tingling of hands, feet or face
- paralysis
- shortness of breath
- weakness (sudden)
You must inform your physician immediately if any of these events occur.
Factors that may affect bleeding risk The following factors may increase your risk of bleeding or clotting
- incomplete understanding of any of your physician's orders about your anticoagulant therapy or not following his/her orders exactly
- you must follow your physician's orders exactly to ensure the anticoagulant is effective without causing serious bleeding
- you must ask your physician about anything you are unsure or concerned about regarding your treatment.
- other medical problems
- make sure you inform your physician if you have any other medical problems, or if you have recently had any medical conditions or procedures
- it is important that you tell your physician if you are currently being treated by any other medical physician or dentist.
- certain combinations of medication
- make sure you tell your physician about all prescribed and over-the-counter drugs that you are taking, including any herbal medications
- make sure you tell your physician about any changes in other prescribed and over-the-counter drugs that you are taking
- if you are prescribed a new drug and you notice any new or unusual bleeding or symptoms, you must alert your physician.
- alcohol
- you should limit your intake of alcohol to 1 or 2 drinks a day and you should try to have a few alcohol-free days each week. Discuss this with your physician for the advice most relevant to you, or if you are uncertain about any previous advice concerning alcohol.
- diet
- you should eat a normal, balanced diet
- you must not make any significant changes to your diet (including dietary supplements) unless you have first informed your physician and received his/her approval. If you do change your diet, it may be necessary to monitor your anticoagulant therapy (e.g. warfarin) more frequently than before.
- vitamin K in your diet (particularly important if you are taking warfarin)
- keep foods containing high levels of vitamin K to a minimum in your diet
- if you are not sure which foods contain vitamin K, check with your physician.
- stomach upset, diarrhea, fever or loss of appetite
- inform your physician if you notice a significant change in your usual appetite over the course of several days because this could affect the amount of vitamin K that gets into your body.
Top
|
|
|
|
|
|
| |
Quick answers to common questions about thrombosis and its treatment.
Go to the Common questions section
|
An alphabetical list of the thrombosis-related terms used on this website. Go here if you want to learn about terms like 'aPTT test', 'LMWH' and 'osteoporosis'.
Go to the Encylopedia
|
|
User feedback is a key factor in how we develop this site in the future. Please send any comments or questions to INATE.
|
|